Life science founders are technical experts in their fields, but frequently fail to understand the needs of the stakeholders who will determine their path to market. This gap sends investors running, and all but ensures immediate or eventual company failure.
Once aware of this gap in knowledge, many are:
GUEST
AUTHOR:

Dr. Lucia Mokres
Founder and Principal, Araneae Biotech Consulting
Dr. Lucia Mokres is a Life Science Consultant based in the San Francisco Bay Area. She specializes in coaching early-stage companies through Stakeholder Ecosystem DiscoverySM, allowing them to gain traction and develop an investable technology and business model. She also loves rolling up her sleeves to help companies at all stages meet urgent medical, scientific, regulatory, and clinical project deadlines, leveraging her broad experience and expertise to rapidly get up to speed and produce high-quality deliverables.
Prior to establishing her consultancy, she was the Chief Medical Officer of EpiBiome, Inc. In this role, she provided medical oversight and strategic direction for all clinical development activities, defined regulatory strategy, supported marketing and business development activities, and served as the medical point of contact for external stakeholders. She was a key contributor for investor pitches and was an invited speaker nationally and internationally on the challenges faced by early-stage companies seeking product approval or clearance. She led EpiBiome through the NSF Innovation Corps and several other incubators and accelerators.
In her spare time, she mentors other early-stage companies through the Springboard Enterprises and California Life Sciences Institute advisory programs, and mentors women completing their PhD and postdoctoral studies on behalf of the Association for Women in Science. Learn More
in collaboration with:
